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Authors’ reply
We thank all correspondents for their 
interest in our report.1 A common 
point is the need for better quality 
studies in this area, which we 
wholeheartedly echo. Quality and 
consistency in reporting, particularly 
of key outcomes such as maternal 
death, stillbirth, and preterm birth, 
are essential if we are to tackle these 
scourges of maternity care.
As always, systematic reviews are 
restricted to covering what has been 
published. Susannah Leisher and 
the International Stillbirth Alliance 
call for the inclusion of a relevant 
preprint paper. We recognised that 
the COVID-19 literature is a rapidly 
evolving field with high rates of 
preprint publication. In consultation 
with editors and reviewers, however, 
we agreed to exclude such papers 
to avoid the pseudo-inflation of the 
sample size and undermine confidence 
in the findings of the analysis, but 
acknowledge that this exclusion might 
have a greater effect on data from 
LMICs, which are recognised to be less 
likely to secure publication.
We agree with Clara Calvert and 
colleagues, and did highlight in our 
Article, that the finding of an increase 
in maternal mortality relied on just 
two data sources, only one of which 
presented national-level data. The 
finding is consistent with another 
report from India not included in 
the quantitative analysis,2 and with 
national-level evidence from Kenya 
reported in a preprint publication.3 But 
we agree that this early identification 
of increased maternal mortality 
cannot necessarily be extrapolated 
throughout the global population and 
that further investigation is required.
We share Lizbeth Ochoa and 
colleagues’ confidence in the finding 
that preterm birth seems to have 
decreased, in high-income countries 
at least, during the COVID-19 
pandemic. We support their call for 
further robust investigations using 
population-level data of a high quality 
and considering stillbirth and preterm 
birth together. They suggest that 
we should have included another 
study in the quantitative synthesis.4 
However, we were unable to include 
this otherwise excellent study because 
the report included four different 
time frames around three different 
implementation dates without 
extractable raw data.
We read with interest Zeus Aranda 
and colleagues’ experiences in 
delivering maternity care at their 
Partners in Health project sites and 
congratulate them on their successes. 
Key lessons include the importance 
of responses to local need based 
on acceptable and available models 
of care and resources, highlighted 
in their community health worker 
programmes in Lesotho, Malawi, 
and Mexico. The response to the 
COVID-19 pandemic has driven an 
explosion in remote access to health 
care, community reporting, and 
the use of technology in a diverse 
range of settings. We should use 
this opportunity to improve the 
coverage of pregnancy and neonatal 
surveillance data.
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